Family Office Real Estate Daily · Family Office Real Estate Research Desk · Preview
Research Desk
A curated index of 20,204 CRE market research reports from the major institutional publishers — filterable by asset class, market and publisher. Editorial Family-Office interpretation layer is rolling out report-by-report.
Showing Family Office Briefings with a Co-GP / Platform angle — each card surfaces how a family office could deploy capital in that market.
94 reports
Page 1 / 4- CBREMay 13, 2026
New York City Life Sciences Figures Q1 2026
Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.
- CBREApr 29, 2026
Philadelphia Life Sciences Figures Q1 2026
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREApr 29, 2026
Lab/R&D Vacancy Rises Despite More Favorable Life Sciences Industry Conditions
Life ScienceFamily Office Briefing →Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.
- CBREApr 17, 2026
Denver/Boulder Life Sciences Figures Q1 2026
Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.
- CBREApr 10, 2026
Boston Metro Life Science Figures Q1 2026
Co-GP / Platform:A family office could deploy into the Boston life science sector by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.
- CBREApr 8, 2026
Bay Area Life Sciences Figures Q1 2026
Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREFeb 18, 2026
San Diego Life Sciences Market Overivew Q4 2025
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong pipeline.
- CBREFeb 11, 2026
New York City Life Sciences Figures Q4 2025
Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.
- CBREFeb 6, 2026
Puget Sound Life Science Figures H2 2025
Co-GP / Platform:A family office could deploy into the Puget Sound life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.
- CBREJan 28, 2026
Life Sciences Vacancy Rate Declines For First Time Since 2022
Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level to capitalize on the improving vacancy landscape.
- CBREJan 21, 2026
Denver/Boulder Life Sciences Figures Q4 2025
Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to align interests and share in the enterprise value.
- CBREJan 16, 2026
Bay Area Life Sciences Figures Q4 2025
Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREJan 14, 2026
Boston Metro Life Science Figures Q4 2025
Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to share in the promote.
- CBRENov 12, 2025
Rise In Life Sciences Vacancy Rate Begins To Slow
Life ScienceFamily Office Briefing →Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.
- CBRENov 5, 2025
San Diego Life Sciences Market Overview Q3 2025
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREOct 22, 2025
New York City Life Sciences Figures Q3 2025
Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust pipeline.
- CBREOct 17, 2025
Bay Area Life Sciences Figures Q3 2025
Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a robust pipeline.
- CBREOct 17, 2025
Denver/Boulder Life Sciences Figures Q3 2025
Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.
- CBREOct 8, 2025
Boston Metro Life Science Figures Q3 2025
Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to align interests and access a robust pipeline.
- CBREAug 8, 2025
San DIego Life Sciences Market Overview Q2 2025
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREAug 6, 2025
Life Sciences Vacancy Rises Despite Increased Leasing Activity & Tenant Requirements
Life ScienceFamily Office Briefing →Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level to capitalize on the evolving leasing landscape.
- CBREAug 6, 2025
Puget Sound Life Science Figures H1 2025
Co-GP / Platform:A family office could deploy into the Puget Sound life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREAug 6, 2025
Philadelphia Life Sciences Figures Report Q2 2025
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREJul 30, 2025
UK Golden Triangle Life Sciences Figures H1 2025
Co-GP / Platform:A family office could deploy into the UK Golden Triangle life sciences market by backing a sponsor or operator through co-GP or JV equity arrangements to share in the promote.
Research Hubs
Dedicated pages for every major publisher and market — each with aggregated KPI medians, asset-class breakdowns and the latest reports, read through a family-office lens.